{"created":"2020-08-30T20:00:32.287731+00:00","id":3127,"links":{},"metadata":{"_buckets":{"deposit":"b62bae2f-7dd7-4547-9104-9b0663eca910"},"_deposit":{"id":"3127","owners":[],"pid":{"revision_id":0,"type":"recid","value":"3127"},"status":"published"},"_oai":{"id":"oai:meral.edu.mm:recid/3127","sets":["1582963366982:1597649530495"]},"communities":["um1"],"item_1583103067471":{"attribute_name":"Title","attribute_value_mlt":[{"subitem_1551255647225":"Single Nucleotide Polymorphism at +276 G>T of the Adiponectin Gene and Plasma Adiponectin Level in Myanmar Type 2 Diabetic Patients","subitem_1551255648112":""}]},"item_1583103085720":{"attribute_name":"Description","attribute_value_mlt":[{"interim":"
Abstract
\nObjective. The aim of the study was to investigate the association between single nucleotide polymorphisms (SNP) at
\nrs 1501299 (SNP+276 G>T) of the adiponectin gene and plasma adiponectin levels in type 2 diabetes mellitus (T2DM)
\npatients in Myanmar.
\nMethodology. One hundred T2DM patients and 104 non-diabetic subjects were included in this cross-sectional analytical
\nstudy. Genotype frequencies were determined by polymerase chain reaction - restriction fragment length polymorphism
\n(PCR-RFLP) method. Plasma adiponectin level was measured by enzyme-linked immunosorbent assay (ELISA).
\nResult. Genotype frequencies (GG, GT, TT) of SNP+276 in diabetic patients were 39%, 48% and 13%, respectively. The
\nGT and TT genotypes were more frequent in T2DM patients (OR 1.98, 95% CI, 1.10-3.55; p=0.02 and OR 4.07, 95%
\nCI, 1.34-12.3; p=0.01), respectively. The T allele of SNP+276 was significantly associated with T2DM (OR 1.96, 95% CI,
\n1.27-3.01; p=0.002). Mean plasma adiponectin level was significantly lower than in T2DM patients (27.41±16.7 μg/mL)
\ncompared to non-diabetic subjects (37.19±26.77 μg/mL) (p=0.002).
\nConclusion. SNP+276 at rs 1501299 of the adiponectin gene was associated with type 2 diabetes and low plasma
\nadiponectin levels in this Myanmar population.